Skip to content
MedGadget – Medical Technology and Healthcare News Website Logo MedGadget

Where Medicine Meets Technology

  • Author
  • Contact Us
  • About Us

Posts by MedGadget Editorial Team

Home - Archives for MedGadget Editorial Team - Page 16

About MedGadget Editorial Team
Varda Series D: $250 million raise to scale pharmaceutical manufacturing in space
Posted inPharmaceutical

Varda Series D: $250M Raise Scales Space Drug Manufacturing

Varda Series D: Varda Space Industries raised $250 million at a $1.6 billion valuation to scale pharmaceutical manufacturing in microgravity.
October 1, 2026
Cigna modernization initiative: $3 billion plan built on AI and automation
Posted inHealthcare IT

Cigna Modernization Initiative: $3 Billion Plan Built on AI

Cigna modernization initiative: the insurer unveiled a $3 billion multi-year plan to streamline workflows with AI-enabled tools at its Investor Day.
October 1, 2026
Supreme Court Drug-Pricing Scrutiny Triggers Broad Sell-Off in Indian Hospital Stocks
Posted inUncategorized

Supreme Court Drug-Pricing Scrutiny Triggers Broad Sell-Off in Indian Hospital Stocks

Shares of major Indian hospital operators fell sharply on September 30, 2026, as investors reacted to the Supreme Court of India's renewed scrutiny of medicine mark-ups at private hospitals. Apollo…
September 30, 2026
Sun Pharma Bond Sale: ₹100 Billion Debt Plan to Refinance Organon Bridge Loan
Posted inPharmaceutical

Sun Pharma Bond Sale: ₹100 Billion Debt Plan to Refinance Organon Bridge Loan

Sun Pharma is reportedly planning a ₹100 billion (about $1.04 billion) rupee bond sale to partly refinance the near-$12 billion bridge loan tied to its pending Organon acquisition, according to Reuters.
September 30, 2026
PharmFormulator Launches Ophthalmic Formulation Database With More Than 1,200 U.S. Drug Records
Posted inPharmaceutical

PharmFormulator Launches Ophthalmic Formulation Database With More Than 1,200 U.S. Drug Records

PharmFormulator LLC has launched PharmFormulator.com, a subscription-based research platform aimed at giving pharmaceutical researchers and healthcare professionals greater access to formulation information for ophthalmic drug products. The database brings together…
September 28, 2026
Lords Mark Advances Radiation-Free Breast Cancer Screening Device Toward Final Clinical Trials
Posted inPress Releases

Lords Mark Advances Radiation-Free Breast Cancer Screening Device Toward Final Clinical Trials

Lords Mark Industries Limited is moving its AI-powered breast cancer screening technology into the final phase of clinical trials, bringing the company closer to its planned commercial launch in international…
September 28, 2026
Estée Lauder Commits $15 Million to Global Research on Breast Cancer in Younger Women
Posted inPress Releases

Estée Lauder Commits $15 Million to Global Research on Breast Cancer in Younger Women

The Estée Lauder Companies is committing $15 million over five years to establish a new international research initiative focused on breast cancer among younger women. Created in partnership with the…
September 25, 2026
HKSH Medical Group Introduces Hong Kong’s First Long-Axial PET/CT for Advanced Cancer Imaging
Posted inPress Releases

HKSH Medical Group Introduces Hong Kong’s First Long-Axial PET/CT for Advanced Cancer Imaging

HKSH Medical Group and United Imaging Healthcare have brought Hong Kong's first long-axial PET/CT system to HKSH Cancer Centre, adding a new imaging platform for cancer diagnosis, treatment planning and…
September 25, 2026
Novo Nordisk Sets $23 Billion Pipeline Sales Target as It Broadens Drug Portfolio
Posted inPress Releases

Novo Nordisk Sets $23 Billion Pipeline Sales Target as It Broadens Drug Portfolio

Novo Nordisk is setting its sights on more than DKK 150 billion, equivalent to roughly $23 billion, in annual risk-adjusted sales from pipeline medicines by 2035 as the pharmaceutical company…
September 24, 2026
Glenmark Launches GLIPIQ Semaglutide in India With Focus on Affordable Type 2 Diabetes Care
Posted inPress Releases

Glenmark Launches GLIPIQ Semaglutide in India With Focus on Affordable Type 2 Diabetes Care

Glenmark Pharmaceuticals has introduced GLIPIQ, a semaglutide-based treatment for Type 2 Diabetes Mellitus, in India, adding a new locally available option to the country's growing market for GLP-1 therapies. The…
September 24, 2026

Posts pagination

Previous page 1 … 14 15 16 17 18 … 25 Next page

All Categories

  • Bio Technology
  • Healthcare IT
  • Healthcare Services
  • Life Science
  • Medical Device
  • Pharmaceutical
  • Press Releases
  • Uncategorized
Copyright 2026 — MedGadget.
Scroll to Top